Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase 4 1Phase 2/3 1

Status

Completed 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 47Breast Neoplasms 34Breast Neoplasms, Male 3Neoplasms 2Neoplasm Metastasis 2Infertility 2Advanced Breast Cancer 2Sexual Dysfunction, Physiological 1Recurrence 1Prostate Adenocarcinoma 1Primary Ovarian Insufficiency 1Osteoporosis 1Osteitis Deformans 1Leiomyoma 1Hot Flashes 1Hemorrhage 1Breast Cancer Invasive 1Anemia 1Advanced Prostate Cancer 1Advanced Metastatic Breast Cancer 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Pemetrexed 9Epoetin Alfa 9venetoclax 8Prednisone 8Fentanyl 8Drug Therapy 8Doxorubicin 8atezolizumab 7Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Goserelin × Clear all
NCT00004635 2018-05-22

Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
159 enrolled 9 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

NCT00605267 2012-09-06

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

AstraZeneca

Phase 3 Completed
197 enrolled 23 charts
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡